Merck Pulls Cholesterol Drug From Shelves


By Molly Clifton

Drug maker Merck is pulling its cholesterol drug Tredaptive.

The drug was never approved in the U.S., but was sold in 40 other countries.

A follow up study shows the medication does not decrease the risk of heart attack and stroke.

This content requires the latest Adobe Flash Player and a browser with JavaScript enabled. Click here for a free download of the latest Adobe Flash Player.

What's onFull Schedule

Hot Video From AP

AP Video